Clinical trials: Microglial Cells Activation Imaging
Microglial Cells Activation Imaging
Microglial Cells Activation Imaging Using PET-CT With 18F-DPA714
There is accumulating evidence suggesting that inflammatory processes, through microglial activation, would play a key role in brain injury and degeneration.
- Trial name
- NCT04171882
- Where
- 2 sites in China
- Volunteers
- 500 people, healthy volunteers welcome
- Sponsor
- Weibing Miao, PhD
Multiple System Atrophy, MSA
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
AZD3241 myeloperoxidase (MPO) inhibitor trial is assessing safety and tolerability, randomized trial, in patients with Multiple System Atrophy.
- Trial name
- NCT02388295
- Testing
- AZD3241
- Where
- 17 sites in United States, Austria and 5 more
- Volunteers
- 59 people
- Sponsor
- AstraZeneca
Glioblastoma
Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study
Imaging of proinflammatory activated microglia by Purine 2X7 (P2X7) receptor scintigraphy in Positron Emission Tomography (PET) scanner in Glioblastoma patients.
- Trial name
- NCT05753995
- Testing
- PET imaging
- Where
- Austria
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Kepler University Hospital
Epilepsy, Post-Traumatic
Imaging of Neuro-Inflammation and the Risk for Post-Traumatic Epilepsy
This study plans to evaluate the time course of inflammation in the brain after a moderate to severe traumatic brain injury using positron emission tomography (PET) brain imaging.
- Trial name
- NCT03999164
- Testing
- [18F]DPA-714 Positron Emission Tomography Scan
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- University of California, Davis
Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive
Novel Imaging Markers in SPMS
This pilot study takes the innovative approach of using ultrasmall superparamagnetic iron oxide (USPIO) nanoparticle enhanced MRI to measure activity of the innate immune system within MS lesions.
- Conditions
- Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis
- Trial name
- NCT05357833
- Testing
- Ferumoxytol infusion, Gadoteridol, MRI Brain and Cervical Spine
- Where
- United States
- Volunteers
- 11 people
- Sponsor
- University of Utah
Healthy
Neuroimmune Response to Lipopolysaccharide
In this study, healthy adult volunteers will undergo two positron emission tomography (PET) scans using the radiotracer [11C]PBR28 which binds to the 18kDa translocator protein (TSPO).
- Trial name
- NCT04233593
- Testing
- Lipopolysaccharide
- Where
- United States
- Volunteers
- 27 people, healthy volunteers welcome
- Sponsor
- Yale University
Multiple Sclerosis
Effect of Ocrelizumab on Neuroinflammation in Multiple Sclerosis as Measured by 11C-PBR28 MR-PET Imaging of Microglia Activation
Using magnetic resonance-PET (MR-PET) imaging with [11C]PBR28, a second-generation 18kDa translocator protein (TSPO) radiotracer, we have previously demonstrated abnormally high TSPO expression, indicative of microglia…
- Trial name
- NCT04230174
- Testing
- 11C-PBR28
- Where
- United States
- Volunteers
- 22 people
- Sponsor
- Massachusetts General Hospital
Prostate Cancer, Mild Cognitive Impairment
PET Imaging in MCI Following ADT for PCa
Mild cognitive impairment (MCI) with ageing is thought in part to be related to reduced serum sex hormones which is well-recognized, especially in females, but poorly understood.
- Trial name
- NCT02061345
- Where
- United Kingdom
- Volunteers
- 11 people
- Sponsor
- Imperial College London